Genesee Capital Advisors’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,709	Closed	-$1.79M	–	84
2022 Q3	$1.79M	Sell	21,709 -647	-3%	-$62.3K	1.37%	16
2022 Q2	$2.13M	Sell	22,356 -2,890	-11%	-$299K	1.49%	16
2022 Q1	$2.97M	Sell	25,246 -364	-1%	-$40.8K	1.55%	15
2021 Q4	$3.32M	Sell	25,610 -636	-2%	-$74.2K	1.58%	15
2021 Q3	$2.97M	Buy	+26,246	New	+$3M	1.47%	18
2021 Q2	–	Sell	-26,860	Closed	-$2.25M	–	69
2021 Q1	$2.25M	Buy	26,860 +3,145	+13%	+$266K	1.33%	21
2020 Q4	$2.16M	Buy	23,715 +33	+0.1%	+$2.74K	1.42%	24
2020 Q3	$1.89M	Sell	23,682 -326	-1%	-$25.4K	1.56%	19
2020 Q2	$1.66M	Sell	24,008 -3,862	-14%	-$274K	1.54%	22
2020 Q1	$1.75M	Sell	27,870 -8,634	-24%	-$623K	1.68%	15
2019 Q4	$2.84M	Sell	36,504 -786	-2%	-$61.4K	2.42%	7
2019 Q3	$2.73M	Sell	37,290 -99	-0.3%	-$6.95K	2.53%	7
2019 Q2	$2.3M	Sell	37,389 -1,368	-4%	-$82.7K	2.32%	9
2019 Q1	$2.47M	Buy	38,757 +2,202	+6%	+$126K	2.97%	7
2018 Q4	$1.87M	Buy	+36,555	New	+$1.85M	3.05%	7